Introduction
Antiretroviral therapy (ART) coverage remains lower in children than adults living with HIV infection globally, with a key reason for this discrepancy being high rates of undiagnosed HIV infection among children.1 Malawi had an estimated 74 000 children ages 0–14 living with HIV in 20192 of whom, approximately only 63% were receiving ART.3 The WHO recommends provider-initiated testing and counselling for all individuals attending any healthcare facility in high HIV prevalence settings as one strategy to identify undiagnosed people living with HIV.4 However, the extent to which provider-initiated testing and counselling is implemented in primary healthcare facilities is variable, especially for children. Recently, there has been a focus on active index testing,5 though, even with this approach, a number of children may be missed.
Lack of HIV testing in children is due to a variety of factors. Healthcare workers (HCWs) may be unaware that some older children living with HIV (CLHIV) may remain without symptoms or have only mild symptoms,6 and therefore, HIV infection in such children and adolescents may go undetected.7 HCWs may also lack proficiency in paediatric HIV management and communication skills with parents to enable implementation of HIV testing in children outside of the early infant diagnosis setting, and mothers may be concerned regarding confidentiality and disclosure of their HIV status to HCWs.8 Moreover, given resource constraints and the lower prevalence of HIV among children compared with adults (1.6% in those aged 0–14 years vs 10.6% among those 15–64 years of age in Malawi),9 it may not be cost-effective to test every child in the outpatient department setting, especially in very high-volume facilities.
In Malawi, children are tested based on HIV exposure or suspicion of infection due to symptoms. For HIV-exposed infants, tests are conducted at 6–8 weeks, 12 months and 24 months. Prior to the introduction of the paediatric HIV screening tool, HIV testing in older children was dependent on HCW suspicion of infection due to the presence of symptoms, resulting in few older children receiving testing.
To address the gap between testing needs and available resources, paediatric HIV screening tools were developed to identify children most at risk for HIV infection, thereby decreasing the overall number of children needing to be tested for HIV, while monitoring the absolute number of CLHIV identified. Such tools, however, must also maximise sensitivity, to reduce the likelihood that a child with HIV infection will miss being tested due to a negative screening test. The ‘cost’ of missing such children is high, as these children are prone to dying earlier from the disease.10 One such screening tool that was designed to be simple and quick to administer is the Zimbabwe HIV risk screening tool (Z-HRST).11 12 This tool can be used by lay cadres in outpatient settings and involves four simple questions about a child’s recent illnesses and family history. This tool was originally tested in non-malaria endemic areas and was shown to be effective.13 However, when applied in malaria endemic areas, the tool was not as successful and this was hypothesised to be primarily due to increased hospitalisation from malaria, resulting in lower sensitivity of hospitalisation as an indicator to identify children at risk for HIV.
In an effort to explore the effectiveness of an adapted paediatric HIV screening tool in a malaria endemic area, the Elizabeth Glaser Paediatric AIDS Foundation (EGPAF), in collaboration with the Malawi Ministry of Health and the Centers for Disease Control and Prevention, tested an adapted version of Z-HRST tool (online supplemental file 1). In addition to the Z-HRST questions, the EGPAF version of the tool asked if the child was admitted to the hospital in the past, and if the hospitalisation was due to malaria, and checked for documented diagnosis for children admitted to the hospital (health passport, discharge summary slip or other records available with the caregiver).
EGPAF sought to validate the modified paediatric screening tool in children aged 2–14 years and their caregivers receiving outpatient services in 16 high-volume health facilities in Malawi. We undertook a study to understand the acceptability of this screening tool among caregivers and its usability and acceptability among expert clients (ECs) administering the tool.